Contrino, J., Hair, G., Kreutzer, D. & Rickles, F.R. In situ detection of expression of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast tissue. Nature Med. 2, 209–215 (1996).
Dvorak, H.F., Senger, D.R., Dvorak, A.M., Harvey, V.S. & McDonagh, J. Regulation of extravascular coagulation by microvascular permeability. Science 227, 1059–1061 (1985).
Senger, D.R. et al. Stimulation of endothelial cell migration by VPF/VEGF through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin and thrombin. in Integrins and Signaling Events in Cell Biology and Disease p. 69, abstract, Keystone Symposium, Jan 5–11, 1996.
Radish, J.L., Butterfield, C.E. & Folkman, J. The effect of fibrin on cultured vascular endothelial cells. Tiss. Cell 11, 99–108 (1979).
Dejana, E., Lampugna, M.G., Giorgi, M., Gaboli, M. & Marchisi, P.C. Fibrinogen induces endothelial-cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor. Blood 75, 1509–1517 (1990).
Dvorak, H.F. et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N. Y. Acad. Sci. 667, 101–111 (1992).
Lawson, C.A. et al. Hypoxia-induced thrombosis is associated with tissue factor expression. Circulation 92, 804 (1995).
Shweiki, D., Itin, A., Softer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
Shima, D.T. et al. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as a mitogen. Mol. Med. 1, 182–193 (1995).
Clauss, M. et al. Vascular permeability factor: A tumor-derived polypeptide which induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535–1545 (1990).
Rak, J.W., St. Croix, B.D. & Kerbel, R.S. Consequences of angiogenesis for tumor progression metastasis and cancer therapy. Anticancer Drugs 6, 3–18 (1995).
Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757–1763 (1995).
O'Reilly, M.S. et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
Holmgren, L., O'Reilly, M.S. & Folkman, J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149–153 (1995).
Teicher, B.A. et al. Potentiation of cytotoxic cancer therapy by TNP-470 alone and with other anti angiogenic agents. Int. J. Cancer 57, 920–925 (1994).
Burrows, F.J. & Thorpe, P.E. Targeting the vasculature of solid tumors. J. Control. Rel. 28, 195–202 (1994).
Weidner, N., Semple, J.P., Welch, W.R. & Folkman, J. Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1–8 (1991).
Weidner, N. Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147, 9–19 (1995).
Rastinejad, F., Polverini, P.J. & Bouck, N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345–355 (1989).
Cheresh, D.A., Berliner, S.A., Vicente, V. & Ruggeri, Z.M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58, 945–953 (1989).
Modzelewski, R. et al. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res. 54, 336–339 (1994).